PetMeds Receives Lowered $3 Takeover Bid from SilverCape Investments
SilverCape Investments has cut its acquisition offer for PetMed Express to $3 per share, down from a prior $4 bid made in December 2025.
PetMed Express, the Nasdaq-listed online pet pharmacy known as PetMeds, confirmed Monday that its board has received a second unsolicited, non-binding, and conditional buyout proposal from SilverCape Investments Limited — this time at $3.00 per share in cash, a full dollar less than the $4.00 per share offer SilverCape submitted back in December 2025.
The reduction in the proposed price is a notable development. When an outside suitor lowers its bid rather than raises it — typically a sign of either deteriorating business fundamentals, failed preliminary due diligence, or a deliberate pressure tactic — it signals a complicated dynamic between the two parties. PetMeds has not indicated whether the board intends to engage with SilverCape or reject the offer outright, describing the proposal only in the formal, arms-length language common to early-stage M&A disclosures.
Read more Nasdaq Moves Market Data Distribution onto Blockchain Infrastructure →
PetMeds has navigated a difficult stretch in the pet health commerce landscape, where competition from large-platform retailers and direct-to-consumer veterinary services has intensified. A below-market or declining acquisition bid can reflect that broader sector pressure, as acquirers attempt to use market softness as negotiating leverage. The conditional and non-binding nature of the proposal means SilverCape retains wide latitude to walk away or revise terms further.
For shareholders, the gap between SilverCape's two offers raises questions about the company's perceived value and whether any eventual deal — if one materializes — would represent fair compensation. Boards in these situations typically retain financial advisors to render a fairness opinion, though PetMeds has made no such announcement publicly. How the board responds to this revised, lower bid will be closely watched by investors in the coming weeks.
Continue reading at GlobalNewswire.
